Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-06 @ 4:10 PM
Last Modification Date: 2024-10-26 @ 2:05 PM
Study NCT ID: NCT04896008
Protocol Section: NCT04896008
Start Identification Module Data
Brief Title: A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality MK-7962-006ZENITH
Official Title: A Phase 3 Randomized Double-Blind Placebo-Controlled Study to Evaluate Sotatercept When Added to Maximum Tolerated Background Therapy in Participants With Pulmonary Arterial Hypertension PAH World Health Organization WHO Functional Class FC III or FC IV at High Risk Mortality
Acronym: ZENITH
Organization: Acceleron Pharma Inc a wholly-owned subsidiary of Merck Co Inc Rahway NJ USA
Organization Class: INDUSTRY
Organization Study ID: 7962-006
Secondary IDs
Secondary ID Type Domain Link
A011-14 OTHER None None
MK-7962-006 OTHER None None
2021-001498-21 EUDRACT_NUMBER Merck None
Start Status Module Data
Status Verified Date: 2024-03
Overall Status: ACTIVE_NOT_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Acceleron Pharma Inc a wholly-owned subsidiary of Merck Co Inc Rahway NJ USA
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Acceleron Pharma Inc a wholly-owned subsidiary of Merck Co Inc Rahway NJ USA
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload